Cyclo Therapeutics Inc. (CYTH)
Market Open
26 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 72
0
0%
$
23.59M Market Cap
- P/E Ratio
- Div Yield
186,806 Volume
0 Eps
$ 0.72
Previous Close Want to track CYTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclo Therapeutics Inc. (CYTH) Statistics
Valuation metrics
Market Cap 23.59M
Enterprise value 15.38M
Trailing P/E (ttm) -0.59
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 21.92
Price/Book (mrq) 2.47
Enterprise Value/Revenue 14.28
Enterprise Value/EBITDA -0.77
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.55
52-Week high 1.62
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 9 Dec 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -18.63%
Operating margin -18.63%
Operational effectiveness
Return on assets -1.51%
Return on equity -7.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.23
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.22
Current ratio (mrq) 1.45%
Book value per share (mrq) 0.29
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
